Locations
United States · San Francisco, CA, USA · San Carlos, CA, USA · Menlo Park, CA, USA · North America
industry
Biotechnology · DeepTech · Hardware · Health · Software
Size
51-200 employees
Stage
Series C+
founded in
2014
Clear Labs harnesses the power of next-generation sequencing (NGS) to simplify complex diagnostics for clinical and applied markets. By creating the only fully-automated platform that brings together DNA sequencing, robotics and cloud-based analytics, Clear Labs democratizes genomics applications to deliver increased clarity. Clear Labs’ turnkey platform accelerates outcomes and improves accuracy - from food-borne pathogens to infectious diseases, including SARS CoV-2. With a novel approach, Clear Labs is helping the world better understand, track and mitigate tomorrow’s novel pathogens.
Something looks off?